Sunday, December 14, 2025
Home Tags Zydus Lifesciences

Tag: Zydus Lifesciences

Zydus and Formycon enter into an Exclusive Partnership for the Licensing and Supply of Biosimilar to Keytruda® (Pembrolizumab), in US and Canada
Collaboration & Partnerships

Zydus and Formycon enter into an Exclusive Partnership for the Licensing and Supply of Biosimilar to Keytruda® (Pembrolizumab), in US and Canada

Author -
0
Zydus receives final approval from USFDA for Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial
Announcement &Achievement

Zydus receives final approval from USFDA for Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial

Passionate in Marketing -
0
Zydus receives final approval from USFDA for Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial
Announcement &Achievement

Zydus receives final approval from USFDA for Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial

Passionate in Marketing -
0
Zydus’ Amplitude receives CE mark for its robotic surgical system ‘Andy’
Announcements & Achievements

Zydus’ Amplitude receives CE mark for its robotic surgical system ‘Andy’

Passionate in Marketing -
0
Zydus receives USFDA Orphan Drug Designation (ODD) for Desidustat for the treatment of beta-thalassemia
Health/ Lifestyle & Entertainment

Zydus receives USFDA Orphan Drug Designation (ODD) for Desidustat for the treatment of beta-thalassemia

Author -
0
Zydus receives NOC from Health Canada for ZDS-Varenicline Tablets 0.5 &1 mg
Industry & Sector-Specific

Zydus receives NOC from Health Canada for ZDS-Varenicline Tablets 0.5 &1 mg

Author -
0
Zydus receives final approval from USFDA for Celecoxib Capsules, 50 mg, 100 mg, 200 mg, and 400 mg
Branding/Advertising

Zydus receives final approval from USFDA for Celecoxib Capsules, 50 mg, 100 mg, 200 mg, and 400 mg

Author -
0
Zydus Gets Exclusive Licensing Rights For Next Gen Immuno-Oncology Platforms From The Us Based Agenus
Health/ Lifestyle & Entertainment

Zydus Gets Exclusive Licensing Rights For Next Gen Immuno-Oncology Platforms From The Us Based Agenus

Author -
0
Zydus to enter global biologics CDMO business Plans to acquire Agenus’ U.S. manufacturing facilities to accelerate development of innovative therapies
Business & Finance

Zydus to enter global biologics CDMO business Plans to acquire Agenus’ U.S. manufacturing facilities to accelerate development of innovative therapies

Author -
0
Zydus Lifesciences’ ‘Easiest Exam’ Campaign a Public Health Initiative in Breast Cancer Awareness reaches millions, wins accolades
Announcements & Achievements

Zydus Lifesciences’ ‘Easiest Exam’ Campaign a Public Health Initiative in Breast Cancer Awareness reaches millions, wins accolades

Author -
0
12Page 1 of 2

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

Passionate in Marketing is promoted by i-miRa Knowledge Solutions, a company founded in 2010 to foster various business units dedicated to creating, disseminating, and managing knowledge-based products, services, and solutions. These offerings cater to corporate entities, startups, and academic institutions alike.

Contact : [email protected]

FOLLOW US

© 2025| Passionate In Marketing |All Rights Reserved | Privacy Policy